Newswire

RegVelo AI Model Predicts Cell Fate, Tackles Developmental Disorders and Cancer

In a new study published in Cell, researchers from Stowers Institute of Medical Research have developed an AI model named RegVelo that bridges two critical aspects of single-cell biology: estimating cellular changes over time and inferring the gene regulatory networks that govern these transformations. This innovative approach could significantly enhance the development of cell therapies in regenerative medicine.

Traditionally, cellular development has been viewed as a series of static snapshots. However, RegVelo models the dynamics of cell fate decisions, revealing how gene regulatory networks operate over time and space. For instance, in zebrafish neural crest development, the model identified key regulators of pigment cell fate, offering insights that may extend to various developmental and oncological contexts.

According to Alejandro Sánchez Alvarado, Stowers President and chief scientific officer, RegVelo’s implications are far-reaching, applicable beyond neural crest cells to any system where cellular changes occur. This model not only describes developmental processes but also generates biologically meaningful hypotheses that can be experimentally validated, thereby advancing our understanding of cellular dynamics and regulatory interactions.

Explore deeper: the API & FDF Intelligence database is more than a directory. It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence. You’ll find: – Price ranges for APIs, excipients, and formulations. – DMF, CEP, and GMP compliance status. – Manufacturer portfolios by product and geography. – Direct contacts for every producer and FDF holder, ready for outreach. Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →